Selected Drugs Clear All
MultiCheck Results
- 1
Interaction
Monitor/Modify Tx |
||
|
imipramine
(generic) + Ongentys
(opicapone) |
||
Monitor/Modify Tximipramine + opicapone monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects) |
||
Additional Considerations |
||
|
octreotide
in Sandostatin LAR Depot
|
||
|
caution advised with narrow therapeutic index drugs extensively metabolized by CYP450 liver enzymes; octreotide inhibition of growth hormone production may decr. CYP450 metabolic function, incr. levels of concomitant drugs, risk of adverse effects caution advised with oral drugs; octreotide alters nutrient absorption, may alter absorption of concomitant drugs, incr. risk of adverse effects or decr. efficacy |
||
|
imipramine
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||